We thank Prajna et al for their comments on our article titled, “Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.”
1At the time of our publication, 1 study had been published from their group, which was referenced,
2The other study was published later than our article and hence were not referenced.
- Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis.Ophthalmology. 2013; 120: 677-681
- Comparison of natamycin and voriconazole for the treatment of fungal keratitis.Arch Ophthalmol. 2010; 128: 672-678
- The Mycotic Ulcer Treatment Trial: a randomized trial comparing natamycin vs voriconazole.Arch Ophthalmol. 2013; 131: 422-429
- Antifungal interactions within the triple combination of amphotericin B, caspofungin and voriconazole against Aspergillus species.J Antimicrob Chemother. 2006; 58: 1168-1176
© 2013 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.